Synthesis and antitumor activity of some novel thiophene, pyrimidine, coumarin, pyrazole and pyridine derivatives 2-Cyano-N-(thiazol-2-yl) acetamide (2a) and 2-cyano-N-(oxazol-2-yl) acetamide (2b) were obtained via the reaction of ethyl cyanoacetate with either 2-aminothiazole (1a) or 2-aminooxazole (1b). The formed products were directed toward the reaction with cyclopentanone and elemental sulfur in the presence of triethylamine to give cyclopenta [b]thiophene derivatives (3a,b). The latter products were reacted with either ethyl cyanoacetate or malononitrile to form compounds 4a,b and 5a,b, respectively. Compounds 4a,b were aimed at synthesizing some heterocyclic compounds; thus internal cyclization reactions were introduced to form compounds 6a,b. Also, compounds 4a,b reacted with salicylaldehyde, hydrazine derivatives and either urea or thiourea to produce coumarin derivatives (7a,b), pyrazole derivatives (8a-d) and pyrimidine derivatives (9a-d), respectively. Reaction of either benzaldehyde or benzene diazonium chloride (11) with compounds 4a,b afforded compounds 10a,b and 12a,b, respectively. On the other hand, compounds 5a,b underwent internal cyclization to form pyrimidine derivatives 13a,b. Also, when compounds 5a,b reacted with either ethyl cyanoacetate or malononitrile, they gave pyridine derivatives (15a-d) through the formation of intermediates (14a-d). Finally, formation of fused pyrimidine derivatives (17a,b) was achieved through the reaction of compounds 5a,b and salicylaldehyde applying two different pathways. The first pathway used a catalytic amount of piperidine to form compounds 16a,b; the latter products underwent cyclization to give compounds 17a,b. The second pathway, using a catalytic amount of sodium ethoxide solution directly in one step, afforded compounds 17a,b. Structures of the newly synthesized compounds were established using IR, 1 H NMR, 13 C NMR and mass spectrometry and their antitumor activity was investigated. Some of these compounds showed promising inhibitory effects on three different cell lines. However, fused pyrimidine acetonitrile derivatives 6a and 6b exerted the highest inhibitory effect, comparable to that of doxorubicin.
Amino-thiophene derivatives were shown to be one of the most important groups of heterocyclic compounds with a wide spectrum of biological activities such as antitumor (1) , antimitotic (2) and antiviral (3) , in addition to either thiazol-amide with fungicidal activity (4) or oxazole-amide with antimicrobial activity (5) . Furthermore, thieno [2,3-d] pyrimidine derivatives show antibacterial (6) and antiproliferative activity (7) . Also, chromene--3-carboxamide acts as an anti-Helicobacter pylori agent (8) and pyrazole derivatives have a specific effect with favorable antitumor activity (9) . In addition, pyridine derivatives show anticonvulsant and anti-inflammatory (10), potential antitubercular (11) and anticonvulsant activity (12) , among others.
In this article, we have described the synthesis of new heterocyclic compounds, thiophene, pyrimidine, coumarin, pyrazole and pyridine derivatives, in an attempt to improve the antitumor activity against three different cell lines: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), and SF-268 (CNS cancer).
EXPERIMENTAL
Melting points were determined in open capillaries and are not corrected. A Yanaco CHN CORDER MT-6 elemental analyzer (Japan) was used. IR spectra were recorded in KBr pellets using a PA-9721 IR spectrophotometer (Shimadzu, Japan). A Jeol 300 MHz (Japan) instrument was used to record the 1 H NMR and 13 C NMR spectra. CD 3 SOCD 3 was used as a solvent and TMS as internal standard. Chemical shifts were expressed as δ (ppm). Kratos (75 eV) MS equipment (Germany) was used for mass spectra recording.
The synthetic pathways used are represented in Schemes 1-4 while the physicochemical and spectral data of the newly synthesized compounds are given in Tables I and II .
Syntheses 2-Cyano-N-(thiazol-2-yl)acetamide (2a) and 2-cyano-N-(oxazol-2-yl)acetamide (2b)
-To a solution of either 2-aminothiazole (1a) (5.007 g, 0.05 mol) or 2-aminooxazole (1b) (4.204 g, 0.05 mol) in 50 mL of absolute ethanol containing triethylamine (0.5 mL) as a catalyst, ethyl cyanoacetate (5.656 g, 0.05 mol) was added and the reaction mixture was heated under reflux for 3 h, cooled and poured onto ice. Conc. HCl (a few drops) was added. The formed precipitate was filtered out and recrystallized from 1,4 dioxane to afford the desired product.
2-Amino-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (3a) and 2-amino-N-(oxazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (3b)
-To a solution of either compound 2a (5.016 g, 0.03 mol) or 2b (4.534 g, 0.03 mol) in 50 mL of absolute EtOH containing triethylamine (1.0 mL), cyclopentanone (2.524g, 0.03 mol) and elemental sulfur (0.96 g, 0.03 mol) were added. The whole reaction mixture was heated under reflux for 2 h, then poured into an ice/water mixture containing a few drops of concentrated hydrochloric acid and the formed solid product, in each case, was collected by filtration and recrystallized from absolute ethanol. 
-To a solution of either compound 3a (5.307 g, 0.02 mol) or 3b (4.986 g, 0.02 mol) in 1,4-dioxane (50 mL) containing triethylamine (0.5 mL), ethyl cyanoacetate (2.262 g, 0.02 mol) was added. The resulting reaction mixture was heated under reflux for 3 h, cooled and poured into an ice/water mixture with a few drops of conc. HCl added. The precipitate that formed was filtered and recrystallized from absolute ethanol. 
2-(1-Amino-2-cyanoethylideneamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (5a) and 2-(1-amino-2-cyanoethylideneamino)-N-(oxazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (5b)
-To a solution of either compound 3a (2.654 g, 0.01 mol) or 3b (2.493 g, 0.01 mol) in 1,4-dioxane (40 mL) containing triethylamine (0.5 mL), malononitrile (0.66 g, 0.01 mol) was added. The reaction mixture was heated under reflux for 2 h, cooled and poured into an ice/water mixture containing a few drops of conc. HCl. The formed precipitate was filtered out and recrystallized from absolute ethanol. [4, 5] thieno [2,3- 
2-(4-Oxo-3-(thiazol-2-yl)-3,4,6,7-tetrahydro-5H-cyclopenta

d]pyrimidin-2-yl)acetonitrile (6a) and 2-(4-oxo-3-(oxazol-2-yl)-3,4,6,7-tetrahydro-5H-cyclopenta[4,5]thieno-[2,3-d]pyrimidin-2-yl)acetonitrile (6b)
. -A suspension of either 4a (0.665 g, 0.002 mol) or 4b (0.633 g, 0.002 mol) in sodium ethoxide (0.002 mol) [prepared by dissolving elemental sodium (0.046 g, 0.002 mol) in abs. EtOH (40 mL)] was heated over a boiling water bath for 6 h and then left to cool. The solid product formed upon pouring onto ice/water containing a few drops of hydrochloric acid (10 %) (until pH = 6). It was collected by filtration and then recrystallized from absolute ethanol.
-To a solution of either compound 4a (0.665 g, 0.002 mol) or 4b (0.633 g, 0.002 mol) in 1,4-dioxane (40 mL) containing piperidine (0.50 mL), salicyladehyde (0.244 g, 0.002 mol) was added. The reaction mixture was heated under reflux for 6 h and then evaporated under vacuum. The remaining product was triturated with absolute ethanol and the formed solid product was collected by filtration and recrystallized from 1,4-dioxane.
2-(5-Amino-1H-pyrazol-3-ylamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (8a), 2-(5-amino-1H-pyrazol-3-ylamino)-N-(oxazol-2-yl)-5,6-dihydro-4H-cyclo penta[b]thiophene-3-carboxamide (8b), 2-(5-amino-1-phenyl-1H-pyrazol-3-ylamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (8c) and 2-(5-amino-1-phenyl-1H-pyrazol-3-ylamino)-N-(oxazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (8d
). -Either compound 4a (0.665 g, 0.002 mol) or 4b (0.633 g, 0.002 mol) was dissolved in absolute ethanol (50 mL) containing piperidine (0.50 mL), hydrazine hydrate (0.1 g, 0.002 mol) or phenylhydrazine (0.216 g, 0.002 mol) and the whole mixture was refluxed for 3 h and then poured into water containing ice and a few drops of concentrated HCl. Suction filtration was then used to collect the coagulated precipitate; the formed solid product was recrystallized from ethanol.
2-(6-Amino-2-oxo-2,5-dihydropyrimidin-4-ylamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (9a), 2-(6-amino-2-oxo-2,5-dihydropyrimidin-4-yl amino)-N-(oxazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (9b), 2-(6-amino-2-thioxo-2,5--dihydropyrimidin-4-ylamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (9c) and 2-(6-amino-2-thioxo-2,5-dihydropyrimidin-4-ylamino)-N-(oxazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (9d
). -To a suspension of either compound 4a (0.665 g, 0.002 mol) or 4b (0.633 g, 0.002 mol) in sodium ethoxide (0.002 mol, 50 mL), either urea (0.12 g, 0.002 mol) or thiourea (0.152 g, 0.002 mol) was added. The whole reaction mixture was heated over a boiling water bath for 3 h, then poured onto ice/water containing a few drops of concentrated hydrochloric acid (until pH 6) and the solid product was collected by filtration and recrystallized from absolute ethanol. Cyano-3-phenylacrylamido)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (10a) and 2-(2-cyano-3-phenylacrylamido)-N-(oxazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (10b). -Either compound 4a (0.665 g, 0. 002 mol) or 4b (0.633 g, 0.002 mol) was dissolved in 50 mL abs. EtOH with added piperidine (0.50 mL). Benzaldehyde (0.21 g, 0.002 mol) was added and the reaction mixture was heated under reflux for 3 h and then poured into ice-containing water with a few drops of conc. HCl added. The coagulated precipitate was collected by suction filtration and recrystallized from 1,4-dioxane. [4, 5] thieno [2,3-d] pyrimidin-2-yl)acetonitrile (13b). -A suspension of either 5a (0.663 g, 0.002 mol) or 5b (0.631 g, 0.002 mol) in sodium ethoxide (50 mL, 0.002 mol) was heated over a boiling water bath for 6 h and then left to cool. The solid product was formed upon pouring it into ice/water containing a few drops of concentrated hydrochloric acid (until pH = 6); it was collected by filtration and recrystallized from absolute ethanol.
2-(2-
2-(3-(Thiazol-2-yl-carbamoyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-2-ylamino)-2-oxo-N'-phenylacetohydrazonoyl cyanide (12a) and 2-(3-(oxazol-2-ylcarbamoyl)-5,6-dihydro-4H-cy clopenta[b]thiophen-2-ylamino)-2-oxo-N'-phenylacetohydrazonoyl cyanide (12b)
.
2-(4-(Aminothiazol-2-yl)-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl) acetonitrile (13a) and 2-(4-(amino-oxazol-2-yl)-6,7-dihydro-5H-cyclopenta
2-(4,6-Diamino-5-cyanopyridin-2-ylamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b] thiophene-3-carboxamide (15a), 2-(4,6-diamino-5-cyanopyridin-2-yl-amino)N-(oxazol-2-yl)5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (15b), 2-(4-amino-5-cyano-6-hydroxylpyridin-2-ylamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (15c) and 2-(4 -amino-5 -cyano-6 -hydroxypyridine-2-ylamino)-N-(oxazol-2-yl)-5,6 -dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (15d)
-To a suspension of either 5a (0.663 g, 0.002 mol) or 5b (0.631 g, 0.002 mol) in sodium ethoxide (0.002 mol, 50 mL), either ethyl cyanoacetate (0.226 g, 0.002 mol) or malononitrile (0.132 g, 0.002 mol) was added. The reaction mixture was heated under reflux for 3 h. It was then poured onto an ice/water mixture containing a few drops of concentrated hydrochloric acid. The formed solid product was collected by filtration and recrystallized from absolute ethanol.
2-(Amino(2-oxo-2H-chromen-3-yl)methyleneamino)-N-(thiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (16a) and 2-(amino(2-oxo-2H-chromen-3-yl)-methyl eneamino)-N-(oxazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (16b
). -To a solution of either compound 5a (0.663 g, 0.002 mol) or 5b (0.631 g, 0.002 mol) in 1,4-dioxane (40 mL) containing piperidine (0.50 mL), salicyladehyde (0.244 g, 0.002 mol) was added. The reaction mixture was heated under reflux for 4 h and then evaporated under vacuum. The remaining product was triturated with absolute ethanol and the crude solid product was collected by filtration and recrystallized from 1,4-dioxane. -thiazol-2-yl)-2-(2-oxo-2H-chromene-3-yl)-6,7 -dihydro-5H-cyclopenta [4, 5] thieno [2,3-d] pyrimidine (17a) and 4-(2-aminooxazol-2-yl)-2-(2-oxo-2H-chromene-3-yl)-6,7 -dihydro-5H-cyclopenta [4, 5] thieno [2,3-d] pyrimidine (17b). -Method A. A solution of either compound 16a (0.872 g, 0.002 mol) or 16b (0.84 g, 0.002 mol) in dimethylformamide (40 mL) containing a catalytic amount of triethylamine (0.5 mL) was heated under reflux for 3 h. It was then poured into an ice/water mixture containing a few drops of conc. HCl. The formed solid product was collected by filtration and recrystallized from 1,4-dioxane.
4-(2-Amino
Method B. To a solution of either compound 5a (0.663 g, 0.002 mol) or 5b (0.631 g, 0.002 mol) in sodium ethoxide (0.002 mol, 50 mL), salicyladehyde (0.244 g, 0.002 mol) was added. The reaction mixture was heated under reflux for 4 h and then evaporated under vacuum. The remaining product was triturated with absolute ethanol and the solid product so formed was collected by filtration and recrystallized from 1,4-dioxane.
Antitumor activity tests: materials and methods
Fetal bovine serum (FBS) and L-glutamine were purchased from Gibco Invitrogen Co. (UK) while RPMI-1640 medium was from Cambrex (USA). Dimethyl sulfoxide (DMSO), doxorubicin, streptomycin, penicillin and sulforhodamine B (SRB) were all from Sigma Chemical Co. (USA).
Three different human tumor cell lines were used: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer) and SF-268 (CNS cancer). MCF-7 was obtained from the European Collection of Cell Cultures (ECACC, Salisbury, UK) while NCI-H460, SF-268 and normal fibroblast cells (WI-38) were kindly donated by the National Cancer Institute (NCI, Cairo, Egypt).
Cell lines grew as monolayers and were routinely maintained in RPMI-1640 medium supplemented with 5 % heat-inactivated FBS, 2 mmol L -1 glutamine and antibiotics (penicillin 100 U mL -1 and streptomycin 100 mg mL -1 ), at 37 o C in a humidified atmosphere containing 5 % CO 2 . Exponentially growing cells were obtained by plating 1.5 × 10 5 cell mL -1 for MCF-7 and SF-268 and 0.75 × 10 4 cell mL -1 for NCI-H460. This was followed by 24-h incubation. The influence of DMSO as a solvent on the growth of cell lines was evaluated in all experiments. It was performed by exposing untreated control cells to the maximum concentration of DMSO used in each assay (0.5 %).
The in vitro tumor cell growth assay was performed according to the procedure described by the National Cancer Institute (USA) (13) . This method uses the protein-binding dye sulforhodamine B to indicate cell growth. Afterwards, exponentially growing cells in 96-well plates were exposed to five serial dilutions of each compound, starting from a maximum concentration of 150 mmol L -1 for 48 h. Following this exposure period, adherent cells were fixed, washed and stained. The bound stain was then dissolved in DMSO and absorbance was measured at 492 nm in a plate reader (Power wave XS, Bio-Tek Instruments, USA). For each test compound and cell line, a dose-dependent curve was established. GI 50 (concentration of the compound that inhibits 50 % of net cell growth) was calculated (14) . Doxorubicin was used as a reference drug (positive control).
ppm that indicated the presence of the CH 2 side group, a multiplet at δ 6.51-6.63 ppm corresponding to 2 H of the thiazole ring and a singlet D 2 O-exchangeable at δ 8.11 ppm corresponding to 1 H of the NH group. Moreover, 13 
Effects on the growth of human tumor cell lines and QSAR
Compounds 2a,b-17a,b were examined for their inhibitory effect on the in vitro growth of human tumor cell lines of different tumor types, namely, breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268). All tested compounds inhibited the growth of the tested tumor cell lines in a dose-dependent manner (data not shown). The results from Table III show that fused pyrimidine acetonitrile derivatives 6a,b exerted the highest inhibitory effect against all three tumor cell lines, comparable with the reference standard. Among the fused pyrimidine derivatives containing coumarin moiety, compounds 17a,b showed the highest inhibitory effects against all three tumor cell lines .  Compounds 2a,b, 13a,b and 15a,b,c,d showed moderate inhibitory effects against all three cancer cell lines, while the rest of the compounds (3a,b, 4a,b, 5a,b, 7a,b, 8a-d, 9a-d, 10a,b,  12a,b and 16a,b) showed low effects.
When comparing fused pyrimidine acetonitrile derivatives, it was found that compound 6b was slightly more effective than 6a, possibly due to the presence of the oxazole ring in 6b instead of the thiazole ring in 6a. On the other hand, for the fused pyrimidine derivatives containing coumarin moiety, it was found that compound 17a with the thiazole ring showed stronger effect than compound 17b containing the oxazole ring. Cyanoacetamide derivatives 2a and 2b showed comparable effects in the presence of the thiazole ring in compound 2a instead of oxazole ring in compound 2b. The same was seen when comparing fused pyrimidine derivatives, 13a with the thiazole ring and 13b with the oxazole ring. Among pyridine derivatives 15a-d, compound 15a was most effective against all three cell lines, possibly due to the presence of the NH 2 group instead of OH group (in 15c and 15d) , in addition to the presence of the thiazole ring instead of the oxazole ring (in 15b).
When comparing the amino-thiophene derivatives 3a,b, acetamido-thiophene derivatives 4a,b and acetimido-thiophene derivatives 5a,b, it was found that these compounds showed almost the same effects despite structural differences (namely, the presence of NH 2 in 3a,b, CNCH 2 CONH in 4a,b and CNCH 2 C=N(NH 2 ) in 5a,b). On the other hand, when comparing coumarin derivatives 7a,b, pyrazole derivatives 8a-d and pyrimidine derivatives 9a-d, it was found that compound 8c was highly effective. This may be due to the presence of the pyrazole ring instead of either coumarin ring in compounds 7a,b or pyrimidine ring in compounds 9a-d, in addition to the phenyl group instead of H (in 8a,b) and thiazole ring instead of oxazole ring (in 8d).
Finally, when comparing benzylidine derivatives 10a,b, phenylhydrazone derivatives 12a,b and coumarin derivatives 16a,b, it was found that these compounds may be of almost the same efficacy despite the presence of the benzylidine side chain in compounds 10a,b, phenylhydrazo side chain in compounds 12a,b and coumarin moiety in compounds 16a,b.
CONCLUSIONS
Among the newly synthesized products, fused pyrimidine acetonitrile derivatives 6a and 6b showed high inhibitory activity against all the three tumor cell lines, MCF-7, NCI-H460 and SF-268, comparable to that of doxorubicine They were followed by fused pyrimidine derivatives containing the coumarin moiety, 17a and 17b.
